Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient
Clinical trial NCT00452361 · TERMINATED
Trial details
- NCT number
- NCT00452361
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.